New review maps the impact of reproductive hormones on neurological health

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University’s Department of Neurology and Neurosurgery maps out the extensive influence of reproductive hormones on neurological health and disease.

Endometriosis linked to increased risk of heart attack and stroke in women

According to research presented at ESC Congress 2024,1 women with endometriosis have a 20% greater risk of significant cardiac outcomes compared with women without endometriosis.

August 29, 2024

FDA approves Syndax’s Revuforj to treat leukaemia

The approval marks the therapy as the first and only menin inhibitor for treating patients one year and older with relapsed or refractory acute leukaemia

November 18, 2024

Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer

MedPage Today brought together three expert leaders in the field — moderator Susana Campos, MD, from the Dana-Farber Cancer Institute in Boston, is joined by

December 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.